Browse the full insider trade history of 카이바이오텍, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 카이바이오텍 has logged 13 public disclosures. The latest transaction was filed on 20 September 2024 (Purchase). Among the most active insiders: 케이비인베스트먼트. All data is accessible without an account.
13
Insider Decl.
0
Thresholds
·
7 ops.
Buy Volume
·
6 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.